Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 17;17(3):379.
doi: 10.3390/pharmaceutics17030379.

Clinical Applications of Targeted Nanomaterials

Ankesh Kumar  1 , S K Shahvej  2 , Pankaj Yadav  1 , Unnati Modi  1 , Amit K Yadav  1 , Raghu Solanki  1 , Dhiraj Bhatia  1
Affiliations
Review

Clinical Applications of Targeted Nanomaterials

Ankesh Kumar et al. Pharmaceutics. .

Abstract

Targeted nanomaterials are at the forefront of advancements in nanomedicine due to their unique and versatile properties. These include nanoscale size, shape, surface chemistry, mechanical flexibility, fluorescence, optical behavior, magnetic and electronic characteristics, as well as biocompatibility and biodegradability. These attributes enable their application across diverse fields, including drug delivery. This review explores the fundamental characteristics of nanomaterials and emphasizes their importance in clinical applications. It further delves into methodologies for nanoparticle programming alongside discussions on clinical trials and case studies. We discussed some of the promising nanomaterials, such as polymeric nanoparticles, carbon-based nanoparticles, and metallic nanoparticles, and their role in biomedical applications. This review underscores significant advancements in translating nanomaterials into clinical applications and highlights the potential of these innovative approaches in revolutionizing the medical field.

Keywords: clinical applications; drug delivery; nanomaterials.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Different types of nanomaterials and their clinical applications.
Figure 2
Figure 2
Historical progress in nanoparticle-based therapies.
Figure 3
Figure 3
Characteristics of nanomaterials.
Figure 4
Figure 4
Challenges in programable nanoparticles.
See this image and copyright information in PMC

References

    1. Wilczewska A.Z., Niemirowicz K., Markiewicz K.H., Car H. Nanoparticles as Drug Delivery Systems. Pharmacol. Rep. 2012;64:1020–1037. doi: 10.1016/S1734-1140(12)70901-5. - DOI - PubMed
    1. Hofmann-Amtenbrink M., Grainger D.W., Hofmann H. Nanoparticles in Medicine: Current Challenges Facing Inorganic Nanoparticle Toxicity Assessments and Standardizations. Nanotechnol. Biol. Med. 2015;11:1689–1694. doi: 10.1016/j.nano.2015.05.005. - DOI - PubMed
    1. Chiari-Andréo B.G., de Almeida-Cincotto M.G.J., Oshiro J.A., Taniguchi C.Y.Y., Chiavacci L.A., Isaac V.L.B. Nanoparticles in Pharmacotherapy. Elsevier; Amsterdam, The Netherlands: 2019. Nanoparticles for Cosmetic Use and Its Application; pp. 113–146.
    1. Wang J. Nanoparticle-Based Electrochemical DNA Detection. Anal. Chim. Acta. 2003;500:247–257. doi: 10.1016/S0003-2670(03)00725-6. - DOI
    1. Peng W., Li S., Guan C., Shen X., Dai Y., Wang Z. Improvement of Magnetorheological Finishing Surface Quality by Nanoparticle Jet Polishing. Opt. Eng. 2013;52:043401. doi: 10.1117/1.OE.52.4.043401. - DOI

LinkOut - more resources